Prevalence of bacterial contamination of glucose test strips in individual single-use packets versus multi-use vials

Journal of Diabetes Science and Technology

Volumn 7, Issue 4, 2013, Pages 854-862

  Pérez Ayala, Millán ^a   Oliver, Paloma ^b   Cantalejo, Fernando Rodriǵuez ^c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Bacterial contamination; Cross contamination; Glucose test strips; Nosocomial infection

Indexed keywords

ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; CLOSTRIDIUM DIFFICILE; COLONY FORMING UNIT; CONTROLLED STUDY; GLUCOSE TOLERANCE TEST; HAND WASHING; HUMAN; MICROBIOLOGICAL EXAMINATION; NONHUMAN; NURSING STAFF; PREVALENCE; STAPHYLOCOCCUS AUREUS; STORAGE; TEST STRIP; WARD; ANALYSIS; BACTERIA; BLOOD GLUCOSE MONITORING; CROSS INFECTION; DEVICES; DRUG CONTAMINATION; DRUG PACKAGING; GLUCOSE BLOOD LEVEL; ISOLATION AND PURIFICATION; MEDICAL DEVICE CONTAMINATION; PROCEDURES; SPAIN; STANDARDS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STATISTICS AND NUMERICAL DATA; BACTERIUM; EQUIPMENT; EQUIPMENT CONTAMINATION; METHODOLOGY; STANDARD; STAPHYLOCOCCUS INFECTION; STATISTICS;

GLUCOSE BLOOD LEVEL; TEST STRIP;

BACTERIA; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CROSS INFECTION; DRUG CONTAMINATION; DRUG PACKAGING; EQUIPMENT CONTAMINATION; HUMANS; PREVALENCE; REAGENT STRIPS; SPAIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 84897121316     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700407     Document Type: Article

References (39)

1. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care. 1994;17(1):S81-6.
2. The Diabetes Control and Complications Trial Research Group. The efect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
3. Olveira-Fuster G, Olvera-Marquez P, Carral-Sanlaureano F, Gonzalez-Romero S, Aguilar-Diosdado M, Soriguer-Escofet F. Excess hospitalizations, hospital days, and inpatient costs among people with diabetes in Andalusia, Spain. Diabetes Care. 2004;27(8):1904-9. (Pubitemid 38989230)
4. Sociedad Española de Medicina Preventiva, Salud Pública e Higiene (SEMPSPH). Estudio de Prevalencia de las Infecciones Nosocomiales en España: EPINE 1990--2011: 22 AÑOS. http://www.sempsph.com/images/ stories/recursos/pdf/protocolos/2012/378-9-epine-1990-2011.pdf. Accesed November 13, 2012.
5. Charvet-Protat S. Medico-economic analysis of nosocomial infections. Presse Med. 2000;29(32):1782-7.
6. Plowman R, Graves N, Griffin MA, Roberts JA, Swan AV, Cookson B, Taylor L. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect. 2001;47(3):198-209. (Pubitemid 32631848)
7. Haley RW, Fischer RP. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore). 2001;80(2):134-51. (Pubitemid 32285210)
8. Ministerio de Sanidady Consumo. Revisión Bibliográfica sobre Trabajos de Costes de la "No Seguridad del Paciente." http://www.msc.es/organizacion/sns/planCalidadSNS/docs/ CostesNoSeguridadPacientes.pdf. Accessed April 17, 2013.
9. Centers for Disease Control (CDC). Public health focus: surveillance, prevention, and control of nosocomial infections. MMWR Morb Mortal Wkly Rep. 1992;41(42):783-7.
10. Burke JP. Infection control - a problem for patient safety. N Engl J Med. 2003;348(7):651-6. (Pubitemid 36204961)
11. World Health Organization. Prevention of hospital-acquired infections. A practical guide. 2nd ed. Geneva: World Health Organization; 2003.
12. Kadi Z, Saint-Laurent P, Cadranel JF, Joly C, Dumouchel P, Jeanne S, Thiers V, Ciurana O, Astagneau P. Retrospective investigation of patients exposed to possible transmission of hepatitis C virus by a capillary blood glucose meter. J Hosp Infect. 2006;63(1):65-9. (Pubitemid 46137423)
13. Desenclos JC, Bourdiol-Razès M, Rolin B, Garandeau P, Ducos J, Bréchot C, Thiers V. Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose. Infect Control Hosp Epidemiol. 2001;22(11):701-7. (Pubitemid 34132011)
14. Thompson ND, Perz JF. Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies. J Diabetes Sci Technol. 2009;3(2):283-8.
15. Louie RF, Lau MJ, Lee JH, Tang Z, Kost GJ. Multicenter study on the prevalence of blood contamination on point-of-care glucose meters and recommendations for controlling contamination. Point Care. 2005;4:158-63.
16. Centers for Disease Control and Prevention. Diabetes and viral hepatitis: important information on glucose monitoring. http://www.cdc.gov/hepatitis/ settings/glucosemonitoring.htm. Accessed November 13, 2012.
17. Bronowicki JP, Venard V, Botté C, Monhoven N, Gastin I, Choné L, Hudziak H, Rihn B, Delanoë C, LeFaou A, Bigard MA, Gaucher P. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med. 1997;337(4):237-40. (Pubitemid 27310439)
18. Izopet J, Pasquier C, Sandres K, Puel J, Rostaing L. Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J Med Virol. 1999;58(2):139-44. (Pubitemid 29226856)
19. Perz JF, Fiore AE. Hepatitis B virus infection risks among diabetic patients residing in long-term care facilities. Clin Infect Dis. 2005;41(5):760-1. (Pubitemid 41170370)
20. Hellinger WC, Grant RL, Hernke DA, Shalev JA, Barber BW, Meek SE, Jones AD, Thompson KM. Glucose meters and opportunities for in-hospital transmission of infection: quantitative assessment and management with and without patient assignment. Am J Infect Control. 2011;39(9):752-6.
21. Vanhaeren S, Duport C, Magneney M, Dumé L, Dumenil AS, Doucet-Populaire F, Decousser JW. Bacterial contamination of glucose test strips: not to be neglected. Am J Infect Control. 2011;39(7):611-3.
22. Ng R, Koo S, Johnston R. Multicenter evaluation of bacterial contamination of glucose test strips. Clin Chim Acta 2012;413:1485-7.
23. Nichols JH. Estimated strip wastage from glucose meter infection control recommendations. Clin Chim Acta. 2012;413(19-20):1485-7.
24. Klonof DC, Perz JF. Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose. J Diabetes Sci Technol. 2010;4(5):1027-31.
25. Wiener-Well Y, Galuty M, Rudensky B, Schlesinger Y, Attias D, Yinnon AM. Nursing and physician attire as possible source of nosocomial infections. Am J Infect Control. 2011;39(7):555-9.
26. Otto M. Staphylococcus epidermidis - the 'accidental' pathogen. Nat Rev Microbiol. 2009;7(8):555-67.
27. Rolston KV, Bodey GP. Infections in patients with cancer. In: Kufe DW, Bast RC Jr, Hait WN, Hong WK, Pollock RE, Weichselbaum RR, Holland JF, Frei E 3rd, eds. Cancer medicine. 7th ed. Hamilton: BC Decker; 2006, 2222-45.
28. Froggatt JW, Johnston JL, Galetto DW, Archer GL. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents Chemother. 1989;33(4):460-6. (Pubitemid 19094273)
29. Announ N, Mattei JP, Jaoua S, Fenollar F, Sati H, Chagnaud C, Roudier J, Guis S. Multifocal discitis caused by Staphylococcus warneri. Joint Bone Spine. 2004;71(3):240-2. (Pubitemid 38739138)
30. Campoccia D, Montanaro L, Visai L, Corazzari T, Poggio C, Pegrefi F, Maso A, Pirini V, Ravaioli S, Cangini I, Speziale P, Arciola CR. Characterization of 26 Staphylococcus warneri isolates from orthopedic infections. Int J Artif Organs. 2010;33(9):575-81.
31. Carretto E, Barbarini D, Couto I, De Vitis D, Marone P, Verhoef J, De Lencastre H, Brisse S. Identification of coagulase-negative staphylococci other than Staphylococcus epidermidis by automated ribotyping. Clin Microbiol Infect. 2005;11(3):177-84. (Pubitemid 40352763)
32. Van Der Zwet WC, Debets-Ossenkopp YJ, Reinders E, Kapi M, Savelkoul PH, Van Elburg RM, Hiramatsu K, Vandenbroucke-Grauls CM. Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit. J Clin Microbiol. 2002;40(7):2520-5. (Pubitemid 34747358)
33. Garza-González E, Morfin-Otero R, Martínez-Vázquez MA, Gonzalez-Diaz E, González-Santiago O, Rodríguez-Noriega E. Microbiological and molecular characterization of human clinical isolates of Staphylococcus cohnii, Staphylococcus hominis, and Staphylococcus sciuri. Scand J Infect Dis. 2011;43(11-12):930-6.
34. Carbon C. MRSA and MRSE: is there an answer? Clin Microbiol Infect. 2000;6 Suppl 2:17-22.
35. Malik RE, Cooper RA, Grifith CJ. Use of audit tools to evaluate the efficacy of cleaning systems in hospitals. Am J Infect Control. 2003;31(3):181-7. (Pubitemid 36793684)
36. Dancer SJ. How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals. J Hosp Infect. 2004;56(1):10-5. (Pubitemid 38029109)
37. Kramer A, Schwebke I, Kampf G; BMC Infectious Diseases. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. http://www.biomedcentral.com/1471-2334/6/130. Accessed March 7, 2013.
38. American Diabetes Association. Bedside blood glucose monitoring in hospitals. Diabetes Care. 2004;27 Suppl 1:S104.
39. Ilyas R, Wallis R, Soilleux EJ, Townsend P, Zehnder D, Tan BK, Sim RB, Lehnert H, Randeva HS, Mitchell DA. High glucose disrupts oligosaccharide recognition function via competitive inhibition: A potential mechanism for immune dysregulation in diabetes mellitus. Immunobiology. 2011;216(1-2):126-31.